VIVE Stock Overview
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Viveve Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.11 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 50.00% |
| 3 Month Change | 50.00% |
| 1 Year Change | -99.36% |
| 3 Year Change | -99.99% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Viveve to get US patent for technology to treat female stress urinary incontinence
Oct 04Viveve Medical receives patent for dual-energy technology in Taiwan
Jul 12Viveve under pressure after upsizes capital raise, prices offering at $3.40
Jan 14Viveve regains compliance with Nasdaq
Dec 17Viveve jumps 19% after FDA clearance for expansion of manufacturing treatment tips
Dec 03Shareholder Returns
| VIVE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | -99.4% | -3.7% | 19.3% |
Return vs Industry: VIVE underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: VIVE underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| VIVE volatility | |
|---|---|
| VIVE Average Weekly Movement | 24.5% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VIVE's share price has been volatile over the past 3 months.
Volatility Over Time: VIVE's weekly volatility has decreased from 951% to 25% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | n/a | www.viveve.com |
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally.
Viveve Medical, Inc. Fundamentals Summary
| VIVE fundamental statistics | |
|---|---|
| Market cap | US$3.22k |
| Earnings (TTM) | -US$28.13m |
| Revenue (TTM) | US$6.83m |
0.0x
P/S Ratio0.0x
P/E RatioIs VIVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VIVE income statement (TTM) | |
|---|---|
| Revenue | US$6.83m |
| Cost of Revenue | US$5.71m |
| Gross Profit | US$1.12m |
| Other Expenses | US$29.25m |
| Earnings | -US$28.13m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VIVE perform over the long term?
See historical performance and comparison